Login to Your Account



GSK Stops Phase II Study of NPS Osteoporosis Drug

By Trista Morrison


Monday, September 29, 2008
NPS Pharmaceuticals Inc. said partner GlaxoSmithKline plc prematurely halted a Phase II trial of osteoporosis drug Ronacaleret (SB-751689) after a planned interim analysis showed a lack of efficacy. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription